Concepedia

Elisabet Megías‐Roda

EM

Statistics

Publications

5

Citations

233

H-Index

5

Active since

2019

Affiliations

Universitat Autònoma de Barcelona(Current)

Vall d'Hebron Institut de Recerca

Ability Pharmaceuticals (Spain)

Institut d'Investigació Biomédica de Bellvitge

Instituto de Investigación Sanitaria del Hospital Clínico San Carlos

Elisabet Megías‐Roda is an author at Universitat Autònoma de Barcelona specializing in autophagy in cancer, oncology, and cancer pharmacology.

ORCID

Publications per year

2019–2022

5

Publications

5

The anti-cancer drug ABTL0812 induces ER stress-mediated cytotoxic autophagy by increasing dihydroceramide levels in cancer cells

Pau Muñoz‐Guardiola, Josefina Casas, Elisabet Megías‐Roda et al. · Autophagy · 2020 · 113 citations · Full text

, , +17

Therapeutic potential of the new TRIB3-mediated cell autophagy anticancer drug ABTL0812 in endometrial cancer

Isidre Felip, Cristian P. Moiola, Cristina Megino‐Luque et al. · Gynecologic Oncology · 2019 · 39 citations

, , +16

The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival

Nora Diéguez-Martínez, Sergio Espinosa-Gil, Guillermo Yoldi et al. · Cellular and Molecular Life Sciences · 2022 · 33 citations · Full text

, , +16

The novel proautophagy anticancer drug ABTL0812 potentiates chemotherapy in adenocarcinoma and squamous nonsmall cell lung cancer

Anna López‐Plana, Patricia Fernández‐Nogueira, Pau Muñoz‐Guardiola et al. · International Journal of Cancer · 2020 · 24 citations · Full text

, , +17

ERK5 Inhibition Induces Autophagy-Mediated Cancer Cell Death by Activating ER Stress

Andrés Gámez-García, Idoia Bolinaga-Ayala, Guillermo Yoldi et al. · Frontiers in Cell and Developmental Biology · 2021 · 24 citations · Full text

, , +17

1–5 of 5